61
Participants
Start Date
February 27, 2016
Primary Completion Date
August 10, 2017
Study Completion Date
May 26, 2018
Evolocumab
Administered by subcutaneous injection
Ezetimibe
Tablet for oral administration
Placebo to Evolocumab
Administered by subcutaneous injection
Placebo Ezetimibe
Tablet for oral administration
Research Site, Nagoya
Research Site, Nagoya
Research Site, Chiba
Research Site, Kisarazu-shi
Research Site, Matsudo-shi
Research Site, Chikushino-shi
Research Site, Koga-shi
Research Site, Sukagawa-shi
Research Site, Sukagawa-shi
Research Site, Hiroshima
Research Site, Kobe
Research Site, Koga-shi
Research Site, Kahoku-gun
Research Site, Kanazawa
Research Site, Komatsu-shi
Research Site, Morioka
Research Site, Morioka
Research Site, Kagoshima
Research Site, Yokohama
Research Site, Kumamoto
Research Site, Kumamoto
Research Site, Kyoto
Research Site, Ohsaki-shi
Research Site, Nakagami-gun
Research Site, Osaka
Research Site, Osaka
Research Site, Fujimi-shi
Research Site, Iruma-gun
Research Site, Kawaguchi-shi
Research Site, Hamamatsu
Research Site, Bunkyo-ku
Research Site, Chuo-ku
Research Site, Higashiyamato-shi
Research Site, Musashino-shi
Research Site, Shinagawa-ku
Lead Sponsor
Amgen
INDUSTRY